معرفی
Nigel Stallard is Professor of Medical Statistics and Director of Warwick Clinical Trials Unit at the University of Warwick. His work focuses on the statistical methodology for clinical trials, with particular expertise in adaptive designs and trial monitoring. He has made significant contributions to the field of medical statistics through his research, editorial work, and leadership of the Warwick Clinical Trials Unit.
Professor Stallard's educational background includes:
- BA in Mathematics from Cambridge University
- MSc in Biometry from the University of Reading
- PhD in Applied Statistics from the University of Reading
Professor Stallard's primary research interests are in the statistical design and analysis of clinical trials. He has worked extensively on optimal trial design and methodology for clinical trials with interim analyses and adaptations such as treatment or subgroup selection. His current work includes developing innovative design methods for clinical trials in small populations and in emerging disease epidemics, as well as methods for decision-making in clinical trials that have been interrupted. His research has significant implications for improving the efficiency and ethical conduct of clinical research across various medical specialties.
His recent publications demonstrate a strong focus on adaptive clinical trial designs, particularly group sequential methods, seamless phase II/III trials, and enrichment designs incorporating biomarkers. There's a clear emphasis on practical applications in various disease areas including cancer, orthopedics, and neurological disorders. His work shows an increasing interest in addressing methodological challenges in trials for rare diseases and during public health emergencies.
Professor Stallard has served as Editor in Chief of the journal Statistics in Medicine. His methodological contributions have been widely cited and implemented in clinical research practice.
Professor Stallard has held major research grants from the National Institute of Health and Social Care Research, the Medical Research Council, and the European Union. His work has directly influenced clinical trial methodology and practice, particularly in the areas of adaptive designs and statistical monitoring. He has collaborated extensively with clinical researchers across multiple disciplines.
As Director of the Warwick Clinical Trials Unit, Professor Stallard leads a team conducting high-quality clinical research across various therapeutic areas. The unit specializes in innovative trial designs and has been involved in numerous national and international collaborative research projects.
حوزههای پژوهشی
